Chemical Structure : PAT-1102
CAS No.: 2641930-61-0
货号: PC-24698Not For Human Use, Lab Use Only.
PAT-1102 (FNDR-20123) is a novel, potent, orally available HDAC inhibitor with IC50 of 3 nM in cell-free HDAC enzymatic assays, also inhibits Plasmodium HDAC with IC50 of 31 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥1580 | In stock | |
5 mg | ¥2480 | In stock | |
10 mg | ¥3980 | In stock | |
25 mg | ¥5980 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PAT-1102 (FNDR-20123) is a novel, potent, orally available HDAC inhibitor with IC50 of 3 nM in cell-free HDAC enzymatic assays, also inhibits Plasmodium HDAC with IC50 of 31 nM.
PAT-1102 (FNDR-20123) inhibits P. falciparum in asexual blood-stage assay with IC50 of 42 nM.
PAT-1102 (FNDR-20123) shows activities against various HDAC isoforms, HDAC1, 2, 3, 6 and 8.
PAT-1102 (FNDR-20123) induces caspase-3 activation in HT-29 cells with EC50 of 1.36 uM.
PAT-1102 (FNDR-20123) exhibits growth-inhibitory properties against a panel of cancer cell lines.
PAT-1102 (FNDR-20123) (50 mg/kg, p.o.) induces significant dose-dependent tumor growth inhibition in subcutaneous xenograft model established with HCT-116 colorectal carcinoma cells in SCID mice.
PAT-1102 (FNDR-20123) exhibits vivo efficacy in a mouse model for Plasmodium falciparum infection.
分子量 | 413.91 | |
分子式 | C21H24ClN5O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzamide, N-hydroxy-4-[[4-[4-(1-pyrrolidinylmethyl)phenyl]-1H-1,2,3-triazol-1-yl]methyl]-, hydrochloride (1:1) |
1. Hiriyan J, et al. Anticancer Res. 2015 Jan;35(1):229-37.
2. Vijay Potluri, et al. Malar J. 2020 Oct 12;19(1):365.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright